Shopping Cart
- Remove All
- Your shopping cart is currently empty
KWAR23 is a monoclonal antibody targeting SIRPα that blocks the interaction of SIRPα and SIRPγ with CD47, impairing chronic T-cell activation and IFN-γ secretion.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $447 | In Stock | |
5 mg | $1,400 | In Stock | |
10 mg | $2,100 | In Stock | |
25 mg | $4,210 | In Stock |
Description | KWAR23 is a monoclonal antibody targeting SIRPα that blocks the interaction of SIRPα and SIRPγ with CD47, impairing chronic T-cell activation and IFN-γ secretion. |
In vitro | The EC50 binding of KWAR23 to SIRPα on human CD14+ monocytes ranged from 0.267 to 0.385 μg/mL. In non-human primates, such as cynomolgus monkeys and rhesus monkeys, KWAR23 binds to CD14+ mononuclear cells with SIRP alpha and EC50 of 0.338 and 0.4, respectively. KWAR23 blocked the binding of CD47 to THP-1 cells, IC50 = 40.82 ng/mL. [1] |
In vivo | KWAR23 showed potent antitumor activity in human SIRPA knock-in mouse models. [1] |
Alias | KWAR 23 |
Molecular Weight | 145.5 |
Smiles | #N/A |
Storage | store at low temperature | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.